|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Developmental pharmacology: drug disposition, action, and therapy in infants and children 显示文摘 | Kearns GL Abdel-Rahman SM Alander SW Blowey DL Leeder JS Kauffman RE | 2003 | N Engl J Med2003，349，12： | 1 |
| 2 | Proton pump inhibitors in pediatrics;mechanism of action,pharmacokinetics,pharmacogenetics,and pharmacodynamics显示文摘 | Ward RM Kearns GL | 2013 | Paediatr Drugs2013，15，2： | 1 |
| 3 | Develop- mental pharmacology-drug disposition, action, and therapy in infants and children 显示文摘 | Kearns GL Abdel-Rahman SM Alander SW | 2003 | N Engl J Med2003，349，12： | 1 |
| 4 | Clinical efficacy and pharmacokinetics of montelukast in dyspeptic children with duodenal eosinophilia 显示文摘 | Friesen CA Kearns GL Andre L | 2004 | J Pediatr Gastroenterol Nutr2004，38，3： | 1 |
| 5 | Pharmacokinetics and safety of montelukast oral granules in children 1 to 3 months of age with bronchiolitis显示文摘 | Kearns GL Lu S Maganti L | 2008 | J Clin Pharmacol2008，48，1： | 1 |
| 6 | Single-dose pharmacokinetics of ibuprofen and acetaminophen in febril children显示文摘 | Brown RD Wilson JT Kearns GL | 1992 | J Clin Pharmacol1992，32，3： | 1 |
| 7 | The pharmacokinctics of continues infusion of pralidoxime in children with orgonophosphate poisoning显示文摘 | Schexnayder S James LP Kearns GL | | 0，，06： | 1 |
| 8 | Developmental pharmacology:drug disposition,action,and therapy in infants and children显示文摘 | Kearns GL Abdel-Rahman SM Alander SW | | 0，，12： | 1 |
| 9 | Pharmacokinetic- sand safety of montelukast oral granules in children 1 to 3 months of age with bronchiolitis显示文摘 | Kearns GL Lu S Maganti L | 2008 | J Clin Pharmacol2008，48，4： | 1 |
| 10 | Pharmacokineticsof montelukast in asthmatic patients 6 to 24 months old显示文摘 | MIGOYA E KEARNS GL HARTFORD A | 2004 | J Clin Pharmacol2004，44，5： | 1 |
| 11 | Single dose pharmacokinetics of linezolid ininfants and children显示文摘 | Kearns GL Abdel RS Blumer JL | 2000 | Pediatr Infect Dis J2000，19，117： | 1 |
| 12 | Pharmacokinetics and safety of montelukast oral granules in children 1 to 3 months of age with bmnchiolitis显示文摘 | Kearns GL Lu S Maganti L | 2008 | J Clin Pharmacol2008，48，4： | 1 |
| 13 | Develop-mental Pharmacology--Drug Disposition,Action,and Therapy in Infants and Children显示文摘 | Kearns GL Abdel-Rahman SM Alander SW | 2003 | N Engl J Med2003，349，： | 1 |
| 14 | Developmental pharmacology-drug disposition,action,and therapy in infants and children显示文摘 | Kearns GL Abdel-Rahman SM Alander SW Blowey DL Leeder JS Kauffman RE | 2003 | N Engl J Med2003，349，12： | 1 |
| 15 | Cytochrome P450 3A: ontogeny and drug disposition显示文摘 | de Wildt SN Kearns GL Leeder JS | 1999 | Clin Pharmacokinet1999，37，6： | 1 |
| 16 | Developmental pharmacology-drug disposition, action , and thera-py in infants and children显示文摘 | KEARNS GL ABDEL-RAHMAN SM ALANDER SW 7 | 2003 | N Engl J Med2003，349，12： | 1 |
| 17 | Developmental pharmacology-drug disposition,action,and therapy in infants and childen显示文摘 | Kearns GL Abdel-Rahman SM Alander SW | 2013 | N Engl J Med2013，349，12： | 1 |
| 18 | The pharmacokinctics of continues infusion of pralidoxime in children with orgonophosphate poisoning显示文摘 | Schexnayder S James LP Kearns GL | 1998 | Clin Toxical1998，36，6： | 1 |
| 19 | Pharmacokinetics and safety of montelukast oral granules in children 1 to 3 months of age with bronehiolitis 显示文摘 | Kearns GL Lu S Maganti L | 2008 | J Clin Pharmaeol2008，48，4： | 1 |
| 20 | Develop mental pharmacology; drug disposition, action, and therapy in infants and children 显示文摘 | Kearns GL Abdel-Rahman SM Alander SW | 2003 | N gngl J Med2003，349，12： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员